A股異動 | 首鋼股份(000959.SZ)競價漲停 現漲幅收窄至不足2% 擬收購京唐公司19.18%股權
格隆匯9月25日丨首鋼股份(000959.SZ)競價漲停,開盤直線回落。現漲幅收窄至不足2%,大幅震盪15%。現報4.39元,暫成交1.6億元,最新總市值232.2億元。擬以55.74億元收購京唐公司19.18%股權。首鋼股份昨日公告,公司擬以向特定對象非公開發行股份的方式購買京投控股持有的京唐公司11.5094%股權、京國瑞持有的京唐公司7.6729%股權。發行價格為4.51元/股。本次交易標的資產京唐公司19.1823%股權的預估交易價格約為55.74億元。本次交易完成後,上市公司直接和間接持有京唐公司100%的股權。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.